1. Home
  2. ICL vs LNTH Comparison

ICL vs LNTH Comparison

Compare ICL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICL
  • LNTH
  • Stock Information
  • Founded
  • ICL 1968
  • LNTH 1956
  • Country
  • ICL Israel
  • LNTH United States
  • Employees
  • ICL 13067
  • LNTH N/A
  • Industry
  • ICL Agricultural Chemicals
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • ICL Industrials
  • LNTH Health Care
  • Exchange
  • ICL Nasdaq
  • LNTH Nasdaq
  • Market Cap
  • ICL 8.8B
  • LNTH 7.5B
  • IPO Year
  • ICL N/A
  • LNTH 2015
  • Fundamental
  • Price
  • ICL $6.74
  • LNTH $81.24
  • Analyst Decision
  • ICL Hold
  • LNTH Strong Buy
  • Analyst Count
  • ICL 2
  • LNTH 5
  • Target Price
  • ICL $6.75
  • LNTH $133.80
  • AVG Volume (30 Days)
  • ICL 685.0K
  • LNTH 1.4M
  • Earning Date
  • ICL 05-19-2025
  • LNTH 05-07-2025
  • Dividend Yield
  • ICL 2.78%
  • LNTH N/A
  • EPS Growth
  • ICL N/A
  • LNTH N/A
  • EPS
  • ICL 0.32
  • LNTH 3.53
  • Revenue
  • ICL $6,841,000,000.00
  • LNTH $1,536,699,000.00
  • Revenue This Year
  • ICL $4.71
  • LNTH $4.96
  • Revenue Next Year
  • ICL $4.08
  • LNTH $10.25
  • P/E Ratio
  • ICL $21.49
  • LNTH $23.00
  • Revenue Growth
  • ICL N/A
  • LNTH 12.53
  • 52 Week Low
  • ICL $3.79
  • LNTH $74.34
  • 52 Week High
  • ICL $6.84
  • LNTH $126.89
  • Technical
  • Relative Strength Index (RSI)
  • ICL 59.22
  • LNTH 32.82
  • Support Level
  • ICL $6.68
  • LNTH $77.01
  • Resistance Level
  • ICL $6.89
  • LNTH $83.60
  • Average True Range (ATR)
  • ICL 0.11
  • LNTH 3.77
  • MACD
  • ICL -0.03
  • LNTH -2.21
  • Stochastic Oscillator
  • ICL 49.88
  • LNTH 13.26

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: